ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesB40

B40

B40 - Blastomycosis

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 B40 is a billable code used to indicate a diagnosis of b40 - blastomycosis.

Key Diagnostic Point:

Blastomycosis is a systemic fungal infection caused by the dimorphic fungus Blastomyces dermatitidis. This organism is primarily found in soil and decaying organic matter, particularly in areas near water bodies in North America. The infection typically occurs when spores are inhaled, leading to pulmonary involvement, but it can disseminate to other organs, including the skin, bones, and central nervous system. Symptoms may range from mild respiratory issues to severe pneumonia, and systemic manifestations can include fever, chills, and weight loss. In immunocompromised patients, such as those with HIV/AIDS or those on immunosuppressive therapy, the risk of severe disease and dissemination is significantly increased. Diagnosis is often confirmed through culture, serology, or histopathological examination of tissue samples. Treatment typically involves antifungal medications such as itraconazole or amphotericin B, depending on the severity of the disease. Early diagnosis and appropriate antifungal therapy are crucial for improving outcomes, especially in high-risk populations.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variability in clinical presentation and severity of the disease.
  • Differentiation from other fungal infections such as histoplasmosis and coccidioidomycosis.
  • Need for accurate documentation of immunocompromised status.
  • Potential for co-infections that may complicate coding.

Audit Risk Factors

  • Inadequate documentation of the patient's immunocompromised status.
  • Failure to document the site of infection (pulmonary vs. disseminated).
  • Incorrect coding of associated conditions or complications.
  • Lack of clarity in treatment plans and response to therapy.

Specialty Focus

Medical Specialties

Infectious Disease

Documentation Requirements

Detailed history of exposure, clinical symptoms, laboratory results, and treatment response.

Common Clinical Scenarios

Patients presenting with respiratory symptoms, fever, and weight loss, particularly in endemic areas.

Billing Considerations

Documentation must clearly indicate the severity of the infection and any underlying immunocompromising conditions.

Pulmonology

Documentation Requirements

Pulmonary function tests, imaging studies, and response to antifungal therapy.

Common Clinical Scenarios

Patients with chronic cough, hemoptysis, or pneumonia-like symptoms.

Billing Considerations

Ensure that the documentation reflects the pulmonary involvement and any complications arising from the infection.

Coding Guidelines

Inclusion Criteria

Use B40 When
  • According to ICD
  • 10 coding guidelines, B40 should be used when there is a confirmed diagnosis of blastomycosis
  • It is important to document the specific site of infection and any complications
  • existing conditions

Exclusion Criteria

Do NOT use B40 When
  • Exclude codes for other fungal infections unless they are co

Related Codes

Child Codes

9 codes
B40.0
Candidal meningitis
B40.1
Candidal meningitis
B40.2
Candidiasis of skin and nail
B40.3
Candidiasis of vulva and vagina
B40.7
Candidal sepsis
B40.8
Other forms of blastomycosis
B40.81
Blastomycotic meningoencephalitis
B40.89
Other forms of blastomycosis
B40.9
Blastomycosis, unspecified

Related CPT Codes

87481CPT Code

Fungal culture

Clinical Scenario

Used when a fungal infection is suspected and culture is needed for diagnosis.

Documentation Requirements

Document the reason for the culture and any prior treatments.

Specialty Considerations

Infectious disease specialists should ensure cultures are sent to appropriate labs for accurate identification.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of blastomycosis, improving data accuracy and facilitating better tracking of fungal infections and their outcomes.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of blastomycosis, improving data accuracy and facilitating better tracking of fungal infections and their outcomes.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of blastomycosis, improving data accuracy and facilitating better tracking of fungal infections and their outcomes.

Resources

Clinical References

  • •
    CDC - Blastomycosis

Coding & Billing References

  • •
    CDC - Blastomycosis

Frequently Asked Questions

What are the common symptoms of blastomycosis?

Common symptoms include cough, fever, chills, night sweats, and weight loss. Skin lesions may also occur in disseminated cases.

How is blastomycosis diagnosed?

Diagnosis is typically made through clinical evaluation, imaging studies, and laboratory confirmation via culture or histopathology.

What is the treatment for blastomycosis?

Treatment usually involves antifungal medications such as itraconazole or amphotericin B, depending on the severity of the infection.